5913 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1735)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2526)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)

More Groups

People
  1. Marc Ladanyi (1326)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (119)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (262)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (757)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5913)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Fundamental immune–oncogenicity trade-offs define driver mutation fitness
    Journal Article

    Hoyos, D.; Zappasodi, R.; Schulze, I.; Sethna, Z.; de Andrade, K. C.; Bajorin, D. F.; Bandlamudi, C.; Callahan, M. K.; Funt, S. A.; Hadrup, S. R.; more...
    Nature (2022)

    Fulltext@MSK | Save
  • Characterization of stage-specific tumor progression in TMPRSS2-ERG (fusion)-driven and non-fusion-driven prostate cancer in GEM models
    Journal Article

    Raina, K.; Kant, R.; Prasad, R. R.; Kandhari, K.; Tomar, M.; Mishra, N.; Kumar, R.; Fox, J. T.; Sei, S.; Shoemaker, R. H.; more...
    Molecular Carcinogenesis (2022)

    Fulltext@MSK | Save
  • Papillary renal cell carcinoma: A single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome
    Journal Article

    Murugan, P.; Jia, L.; Dinatale, R. G.; Assel, M.; Benfante, N.; Al-Ahmadie, H. A.; Fine, S. W.; Gopalan, A.; Sarungbam, J.; Sirintrapun, S. J.; more...
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • FGFR2::TACC2 fusion as a novel KIT-independent mechanism of targeted therapy failure in a multidrug-resistant gastrointestinal stromal tumor
    Journal Article

    Dermawan, J. K.; Vanderbilt, C. M.; Chang, J. C.; Untch, B. R.; Singer, S.; Chi, P.; Tap, W. D.; Antonescu, C. R.
    Genes Chromosomes and Cancer (2022)

    Fulltext@MSK | Save
  • Phase II study of neoadjuvant nivolumab in patients with locally advanced clear cell renal cell carcinoma undergoing nephrectomy
    Journal Article

    Carlo, M. I.; Attalla, K.; Mazaheri, Y.; Gupta, S.; Yildirim, O.; Murray, S. J.; Coskey, D. T.; Kotecha, R.; Lee, C. H.; Feldman, D. R.; more...
    European Urology (2022)

    Fulltext@MSK | Save
  • Prolonged survival of anaplastic thyroid carcinoma is associated with resectability, low tumor-infiltrating neutrophils/myeloid-derived suppressor cells, and low peripheral neutrophil-to-lymphocyte ratio
    Journal Article

    Xu, B.; Zhang, L.; Setoodeh, R.; Mohanty, A. S.; Landa, I.; Balzer, B.; Tiedje, V.; Ganly, I.; Dogan, S.; Fagin, J. A.; more...
    Endocrine (2022)

    Fulltext@MSK | Save
  • TERT copy number alterations, promoter mutations and rearrangements in adrenocortical carcinomas
    Journal Article

    Gupta, S.; Won, H.; Chadalavada, K.; Nanjangud, G. J.; Chen, Y. B.; Al-Ahmadie, H. A.; Fine, S. W.; Sirintrapun, S. J.; Strong, V. E.; Raj, N.; more...
    Endocrine Pathology (2022)

    Fulltext@MSK | Save
  • Change in neutrophil-to-lymphocyte ratio during neoadjuvant treatment does not predict pathological response and survival in resectable pancreatic ductal adenocarcinoma
    Journal Article

    Strong, J. S.; Vos, E. L.; McIntyre, C. A.; Chou, J. F.; Gonen, M.; Tang, L. H.; Soares, K. C.; Balachandran, V. P.; Kingham, T. P.; D'Angelica, M. I.; more...
    American Surgeon (2022)

    Fulltext@MSK | Save
  • ILC2s-Bipartisan politicians in cancer
    Review

    Zebboudj, A.; Amisaki, M.; Balachandran, V. P.
    Science Immunology (2022)

    Fulltext@MSK | Save
  • MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT
    Journal Article

    Andrlová, H.; Miltiadous, O.; Kousa, A. I.; Dai, A.; DeWolf, S.; Violante, S.; Park, H. Y.; Janaki-Raman, S.; Gardner, R.; El Daker, S.; more...
    Science Translational Medicine (2022)

    Fulltext@MSK | Save